OHSU

Robert L. Schelonka, M.D.

Head Shot of Robert Schelonka

Associate Professor

Email: 
click here

Background

Dr. Schelonka's research focuses on understanding the cellular and molecular basis for the relative immune deficiency of infancy and the unusually high risk of developing serious infections in prematurely born infants. Generating knock in targeted mutations of the alleles encoding the T and B cell antigen receptors in mice, Dr. Schelonka has shown how alterations in the immune repertoire affect the host response to specific antigens. Dr. Schelonka has participated in clinical trials examining the efficacy of immune-modifying monoclonal and polyclonal antibody preparations to enhance immune function and reduce the risk of developing serious bacterial or fungal infection.


Selected Publications

"Recirculating bone marrow B cells in C57BL/6 mice are more tolerant of highly hydrophobic and highly charged CDR-H3s than those in BALB/c mice," European Journal of Immunology (Vol: 43, Issue: 3, Page 629-640) - 2013

"Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections," Clinical Infectious Diseases (Vol: 55, Issue: 11, Page 1495-1502) - 2012

"Cytokine profiles of preterm neonates with fungal and bacterial sepsis," Pediatric Research (Vol: 72, Issue: 2, Page 212-220) - 2012

"Type V Aplasia Cutis Congenita: Case Report, Review of the Literature, and Proposed Treatment Algorithm," Pediatric Dermatology (Vol: , Issue: , Page ) - 2012

"Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: A randomized trial," Journal of Pediatrics (Vol: 159, Issue: 6, Page 900-906.e1) - 2011

 

OHSU Doernbecher Children's Hospital

Visit Our Site

For Healthcare Professionals


Contact

  Email Robert Schelonka

503 494-8311

Memberships & Associations

American Academy of Pediatrics, Society for Pediatric Research